Skip to content

Clinical trials

Phase 2 Esophageal Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 2 Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20122
20131
20141
20172
20181
20191
20201
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status5
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Royal Marsden NHS Foundation Trust4
University of Southampton2
AstraZeneca1
Daiichi Sankyo1
Fiona Thistlethwaite1
Lisette Nixon1
Merck KGaA, Darmstadt, Germany1
PharmaEngine1
Seagen Inc.1
Simon C Pacey, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms16
Stomach Neoplasms10
Adenocarcinoma3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Ovarian Neoplasms2
Prostatic Neoplasms2
Urinary Bladder Neoplasms2
Uterine Cervical Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.